Perceived clinical utility of a test for predicting inadequate response to TNF inhibitor therapies in rheumatoid arthritis: results from a decision impact study

Overview of attention for article published in Rheumatology International, November 2020

Altmetric Badge

About this Attention Score

In the top 5% of all research outputs scored by Altmetric
One of the highest-scoring outputs from this source (#3 of 2,503)
High Attention Score compared to outputs of the same age (99th percentile)
High Attention Score compared to outputs of the same age and source (97th percentile)

Mentioned by

news: 39 news outlets

twitter: 5 X users

Citations

dimensions_citation: 4 Dimensions

Readers on

mendeley: 17 Mendeley

Summary News X Dimensions citations

So far, Dimensions has found 4 publications that cite this research output.

4

The most recent citing publications are shown below. View all 4 publications that cite this research output on Dimensions.

Patient outcomes improve when a molecular signature test guides treatment decision-making in rheumatoid arthritis

Article in Expert Review of Molecular Diagnostics (October 2022)

Analytical and clinical validation of an RNA sequencing-based assay for quantitative, accurate evaluation of a molecular signature response classifier in rheumatoid arthritis

Article in Expert Review of Molecular Diagnostics (November 2021)

Guided therapy selection in rheumatoid arthritis using a molecular signature response classifier: an assessment of budget impact and clinical utility

Article in Journal of Managed Care & Specialty Pharmacy (October 2021)